CLINICAL_TRIALS
trial_result
· 2016-08-18
Clinical Trial Update: Combining Lesinurad With Allopurinol in Inadequate Responders [Phase 3]
Summary
A Phase 3 trial evaluated adding lesinurad to allopurinol in gout patients who did not respond adequately, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardea Biosciences, Inc. | Conditions: Gout | Phase 3 | Status: COMPLETED | Results posted: 2016-08-18